Inmaculada Hernandez Y Delso

Title(s)Associate Professor, School of Pharmacy and Pharmaceutical Science
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
Emailinhernandez@ucsd.edu
ORCID ORCID Icon0000-0002-0118-4986 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of Pittsburgh, Pittsburgh, PAPhD06/2016Health Services Research and Policy
    University of Navarra, Pamplona (Spain)PharmD06/2013Pharmacy
    Collapse Awards and Honors
    National Academy of Medicine2022  - 2024National Academy of Medicine Fellow in Pharmacy
    Academy Health2021Alice S. Hersh Emerging Leader Award
    American Journal of Managed Care2019Seema S. Sonnad Emerging Leader in Managed Care Research Award
    Forbes2018Forbes 30 Under 30
    American Heart Association2019Fellow
    American College of Cardiology2018Fellow
    Rho Chi Society2019Outstanding Scholarly Contribution Award
    Delta Omega National Public Health Honor Society Omicron Chapter 2017Best Doctoral Dissertation Award
    Delta Omega Honorary Society2019Delta Omega Public Health Honor Society Inductee

    Collapse Overview 
    Collapse Overview
    I began my faculty career at the University of Pittsburgh in 2016. I joined the University of California, San Diego (UCSD) as an Associate Professor with tenure in 2021. My research has focused on evaluating clinical and economic outcomes of oral anticoagulation and studying pharmaceutical pricing. I have published over 100 peer-reviewed scientific manuscripts with 70 as first or senior author. Some of these articles have been published in top-tier journals, including JAMA, Annals of Internal Medicine, JAMA Internal Medicine, JAMA Oncology, JAMA Neurology, JAMA Dermatology, Health Affairs, and Stroke. My research has been covered by media worldwide, and has been featured in the main US outlets, including New York Times, Washington Post, NPR, CNN, Forbes, BBC, ABC, CNBC, or Bloomberg.

    I am the PI of a K01 and an R01 to study oral anticoagulation use in atrial fibrillation. I was tenured and awarded my first R01 as PI at the age of 30. I was recently selected as the 2022-2024 National Academy of Medicine Fellow in Pharmacy. In 2021, I became the first pharmacist to be recognized with the Academy Health Alice S. Hersh Emerging Leader Award. This recognition is one of the highest honors for early-career health policy scholars. In 2018, I was recognized on the Forbes 30 under 30 list. I am a fellow of the American College of Cardiology and the American Heart Association.
    Collapse In The News

    Collapse Research 
    Collapse Research Activities and Funding
    Pricing and Discounting Dynamics Associated with Significant Events over the Life Cycle of a Drug
    West Health Policy Center Aug 25, 2022 - Dec 31, 2023
    Role: PI
    Effect of Competition on Pharmaceutical Manufacturer Discounts and Prices
    West Health Policy Center Sep 1, 2021 - Aug 31, 2022
    Role: PI
    Pandemic Disruptions of Atrial Fibrillation Care
    NIH R01HL157051Jul 1, 2021 - Jun 30, 2025
    Role: PI
    Patient and System-Level Determinants of Oral Anticoagulation Use in Atrial Fibrillation
    NIH K01HL142847Jul 15, 2018 - Jun 30, 2023
    Role: PI

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Disparities in distribution of COVID-19 vaccines across US counties: A geographic information system-based cross-sectional study. PLoS Med. 2022 07; 19(7):e1004069. Hernandez I, Dickson S, Tang S, Gabriel N, Berenbrok LA, Guo J. PMID: 35901171; PMCID: PMC9333439.
      View in: PubMed   Mentions:    Fields:    
    2. Reduction in Medicaid Rebates Paid by Pharmaceutical Manufacturers for Outpatient Injected, Inhaled, Infused, Implanted, or Instilled Drugs: The 5i Loophole. J Health Polit Policy Law. 2022 Jul 14. Dickson S, Gabriel N, Gellad W, Hernandez I. PMID: 35867551.
      View in: PubMed   Mentions:    Fields:    
    3. Income disparities in driving distance to health care infrastructure in the United States: a geographic information systems analysis. BMC Res Notes. 2022 Jun 27; 15(1):225. Guo J, Hernandez I, Dickson S, Tang S, Essien UR, Mair C, Berenbrok LA. PMID: 35761413; PMCID: PMC9235217.
      View in: PubMed   Mentions:    Fields:    
    4. Consequences of forgoing prescription drug subsidies among low-income Medicare beneficiaries with diabetes. Health Serv Res. 2022 Oct; 57(5):1136-1144. Glynn A, Hernandez I, Roberts ET. PMID: 35430735; PMCID: PMC9441281.
      View in: PubMed   Mentions:    Fields:    
    5. Association of formulary restrictions and initiation of an SGLT2i or GLP1-RA among Medicare beneficiaries with type 2 diabetes. Diabetes Res Clin Pract. 2022 May; 187:109855. Luo J, Gabriel N, Korytkowski M, Hernandez I, Gellad WF. PMID: 35346753.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Identifying Patients at Risk of Acute Kidney Injury Among Medicare Beneficiaries With Type 2 Diabetes Initiating SGLT2 Inhibitors: A Machine Learning Approach. Front Pharmacol. 2022; 13:834743. Yang L, Gabriel N, Hernandez I, Vouri SM, Kimmel SE, Bian J, Guo J. PMID: 35359843; PMCID: PMC8961669.
      View in: PubMed   Mentions:
    7. Effect of the COVID-19 pandemic on adversity in individuals receiving anticoagulation for atrial fibrillation: A nationally representative administrative health claims analysis. Am Heart J Plus. 2022 Jan; 13:100096. Hernandez I, Gabriel N, He M, Guo J, Tadrous M, Suda KJ, Magnani JW. PMID: 35136865; PMCID: PMC8815277.
      View in: PubMed   Mentions:
    8. Comparison of oral anticoagulation use and adherence among Medicare beneficiaries enrolled in stand-alone prescription drug plans vs Medicare Advantage prescription drug plans. J Manag Care Spec Pharm. 2022 Feb; 28(2):266-274. Newman TV, Gabriel N, Liang Q, Drake C, El Khoudary SR, Good CB, Gellad WF, Hernandez I. PMID: 35098746; PMCID: PMC8856760.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. The global impact of COVID-19 on drug purchases: A cross-sectional time series analysis. J Am Pharm Assoc (2003). 2022 May-Jun; 62(3):766-774.e6. Suda KJ, Kim KC, Hernandez I, Gellad WF, Rothenberger S, Campbell A, Malliart L, Tadrous M. PMID: 35094929; PMCID: PMC8704785.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    10. COVID-19 and Anticoagulation for Atrial Fibrillation: An Analysis of US Nationwide Pharmacy Claims Data. J Am Heart Assoc. 2021 12 21; 10(24):e023235. Hernandez I, Gabriel N, He M, Guo J, Tadrous M, Suda KJ, Magnani JW. PMID: 34913359; PMCID: PMC9075244.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    11. Primary care provider payment models and adherence to anticoagulation in patients with atrial fibrillation. J Manag Care Spec Pharm. 2021 Dec; 27(12):1672-1679. Yang L, Guo J, Liang Q, Newman TV, Gellad WF, Hernandez I. PMID: 34818086; PMCID: PMC8856758.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Racial and Urban-Rural Difference in the Frequency of Ischemic Stroke as Initial Manifestation of Atrial Fibrillation. Front Public Health. 2021; 9:780185. Guo J, Gabriel N, Magnani JW, Essien UR, Gellad WF, Brooks MM, Trinquart L, Benjamin EJ, Hernandez I. PMID: 34805085; PMCID: PMC8602106.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Non-persistence to Oral Anticoagulation Treatment in Patients with Non-valvular Atrial Fibrillation in the USA. Am J Cardiovasc Drugs. 2022 May; 22(3):333-343. Dhamane AD, Hernandez I, Di Fusco M, Gutierrez C, Ferri M, Russ C, Tsai WL, Emir B, Yuce H, Keshishian A. PMID: 34671944; PMCID: PMC9061668.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. Emerging treatments for lupus nephritis: health equity considerations in clinical research and coverage. J Manag Care Spec Pharm. 2021 Oct; 27(10):1500-1502. Newman TV, Guo J, Hernandez I. PMID: 34595947.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Are novel glucose-lowering agents' cardiorenal benefits generalizable to individuals of Black race? A meta-trial sequential analysis to address disparities in cardiovascular and renal outcome trials enrolment. Diabetes Obes Metab. 2022 01; 24(1):154-159. Tang H, Kimmel SE, Hernandez I, Brooks MM, Cusi K, Smith SM, Shi W, Winterstein AG, Magnani JW, Guo J. PMID: 34472689.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    16. The Costs of Delayed Generic Drug Entry: Evidence from a Controversial Prostate Cancer Drug Patent. J Gen Intern Med. 2022 02; 37(3):668-670. Miller D, Ippolito B, Hernandez I, Davies B. PMID: 34258725; PMCID: PMC8858345.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Cost-effectiveness of Dapagliflozin for the Treatment of Heart Failure With Reduced Ejection Fraction. JAMA Netw Open. 2021 07 01; 4(7):e2114501. Isaza N, Calvachi P, Raber I, Liu CL, Bellows BK, Hernandez I, Shen C, Gavin MC, Garan AR, Kazi DS. PMID: 34313742; PMCID: PMC8317009.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    18. Marked Increase in Sales of Erectile Dysfunction Medication During COVID-19. J Gen Intern Med. 2021 09; 36(9):2912-2914. Hernandez I, Gul Z, Gellad WF, Davies BJ. PMID: 34170453; PMCID: PMC8229258.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    19. Trends in the Use of Conventional and New Pharmaceuticals for Hemophilia Treatments Among Medicaid Enrollees, 2005-2020. JAMA Netw Open. 2021 06 01; 4(6):e2112044. Hernandez I, Rowe D, Gellad WF, Good CB. PMID: 34076701; PMCID: PMC8173373.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    20. A decade of increases in Medicare Part B pharmaceutical spending: what are the drivers? J Manag Care Spec Pharm. 2021 May; 27(5):565-573. San-Juan-Rodriguez A, Gellad WF, Shrank WH, Good CB, Hernandez I. PMID: 33908276; PMCID: PMC8906185.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Joint Latent Class Analysis of Oral Anticoagulation Use and Risk of Stroke or Systemic Thromboembolism in Patients with Atrial Fibrillation. Am J Cardiovasc Drugs. 2021 Sep; 21(5):573-580. Chen N, Gabriel N, Brooks MM, Hernandez I. PMID: 33844177; PMCID: PMC8440356.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. Impact of the COVID-19 Pandemic on Global Anticoagulant Sales: A Cross-Sectional Analysis Across 39 Countries. Am J Cardiovasc Drugs. 2021 09; 21(5):581-583. Hernandez I, Tadrous M, Magnani JW, Guo J, Suda KJ. PMID: 33768423; PMCID: PMC7994109.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    23. Using machine learning to identify diabetes patients with canagliflozin prescriptions at high-risk of lower extremity amputation using real-world data. Pharmacoepidemiol Drug Saf. 2021 05; 30(5):644-651. Yang L, Gabriel N, Hernandez I, Winterstein AG, Guo J. PMID: 33606340.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. Association between opioid dose escalation and time to death in a comfort measures only population. Am J Health Syst Pharm. 2021 01 22; 78(3):203-209. Abraham DL, Hernandez I, Ayers GT, Pruskowski JA. PMID: 33064125; PMCID: PMC7797738.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    25. Trends in list prices, net prices, and discounts of self-administered injectable tumor necrosis factor inhibitors. J Manag Care Spec Pharm. 2021 Jan; 27(1):112-117. San-Juan-Rodriguez A, Piro VM, Good CB, Gellad WF, Hernandez I. PMID: 33377437; PMCID: PMC7788267.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Coverage, Formulary Restrictions, and Out-of-Pocket Costs for Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide 1 Receptor Agonists in the Medicare Part D Program. JAMA Netw Open. 2020 10 01; 3(10):e2020969. Luo J, Feldman R, Rothenberger SD, Hernandez I, Gellad WF. PMID: 33057641; PMCID: PMC7563069.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    27. Trends in List and Net Prices of Self-administered Systemic Psoriasis Therapies Manufactured by US-Based Pharmaceutical Companies. JAMA Dermatol. 2020 10 01; 156(10):1136-1138. Ferris LK, Gellad WF, Hernandez I. PMID: 32785612; PMCID: PMC7557512.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    28. Effectiveness and Safety of Restarting Oral Anticoagulation in Patients with Atrial Fibrillation after an Intracranial Hemorrhage: Analysis of Medicare Part D Claims Data from 2010-2016. Am J Cardiovasc Drugs. 2020 Oct; 20(5):471-479. Newman TV, Chen N, He M, Saba S, Hernandez I. PMID: 31808136; PMCID: PMC7274872.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    29. Estimating Discounts for Top Spending Drugs in Medicare Part D. J Gen Intern Med. 2021 08; 36(8):2503-2505. Hernandez I, San-Juan-Rodriguez A, Good CB, Gellad WF. PMID: 32909227; PMCID: PMC8342628.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    30. Drug Shortages and Group Purchasing Organizations-Reply. JAMA. 2020 08 25; 324(8):809. Donohue JM, Hernandez I, Hershey TB. PMID: 32840590.
      View in: PubMed   Mentions: 1     Fields:    
    31. Drug Prices, Rebates, and Discounts-Reply. JAMA. 2020 07 28; 324(4):399-400. Hernandez I, Gellad WF. PMID: 32721000.
      View in: PubMed   Mentions:    Fields:    
    32. Evaluation of Frequency of Encounters With Primary Care Physicians vs Visits to Community Pharmacies Among Medicare Beneficiaries. JAMA Netw Open. 2020 07 01; 3(7):e209132. Berenbrok LA, Gabriel N, Coley KC, Hernandez I. PMID: 32667653; PMCID: PMC7364370.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    33. Comparison of Oral Anticoagulant Use and Stroke Risk Among Older Adults Newly-Diagnosed Atrial Fibrillation Living in Urban-Versus-Rural Areas. Am J Cardiol. 2020 09 01; 130:64-69. Guo J, He M, Magnani JW, Brooks MM, Gellad WF, Hernandez I. PMID: 32680675; PMCID: PMC8040970.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    34. Interpreting COVID-19 Test Results: a Bayesian Approach. J Gen Intern Med. 2020 08; 35(8):2490-2491. Good CB, Hernandez I, Smith K. PMID: 32495086; PMCID: PMC7269418.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsPHPublic Health
    35. The Skyrocketing Cost of Rectal Indomethacin. JAMA Intern Med. 2020 05 01; 180(5):631-632. Elmunzer BJ, Hernandez I, Gellad WF. PMID: 32150228; PMCID: PMC7483935.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    36. Real-World Direct Comparison of the Effectiveness and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Medicare Beneficiaries With Atrial Fibrillation. Am J Cardiol. 2020 07 01; 126:29-36. Yang L, Brooks MM, Glynn NW, Zhang Y, Saba S, Hernandez I. PMID: 32359718; PMCID: PMC7275920.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    37. Adherence to Anticoagulation and Risk of Stroke Among Medicare Beneficiaries Newly Diagnosed with Atrial Fibrillation. Am J Cardiovasc Drugs. 2020 Apr; 20(2):199-207. Hernandez I, He M, Brooks MM, Saba S, Gellad WF. PMID: 31523759; PMCID: PMC7073283.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    38. Drug Shortages in the United States: Are Some Prices Too Low? JAMA. 2020 Mar 03; 323(9):819-820. Hernandez I, Hershey TB, Donohue JM. PMID: 32125409; PMCID: PMC7099531.
      View in: PubMed   Mentions: 2     Fields:    
    39. Changes in List Prices, Net Prices, and Discounts for Branded Drugs in the US, 2007-2018. JAMA. 2020 03 03; 323(9):854-862. Hernandez I, San-Juan-Rodriguez A, Good CB, Gellad WF. PMID: 32125403; PMCID: PMC7054846.
      View in: PubMed   Mentions: 28     Fields:    
    40. Race/Ethnicity and Sex-Related Differences in Direct Oral Anticoagulant Initiation in Newly Diagnosed Atrial Fibrillation: A Retrospective Study of Medicare Data. J Natl Med Assoc. 2020 Feb; 112(1):103-108. Essien UR, Magnani JW, Chen N, Gellad WF, Fine MJ, Hernandez I. PMID: 32035755; PMCID: PMC7183759.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    41. Latent Classes of Adherence to Oral Anticoagulation Therapy Among Patients With a New Diagnosis of Atrial Fibrillation. JAMA Netw Open. 2020 02 05; 3(2):e1921357. Chen N, Brooks MM, Hernandez I. PMID: 32074287; PMCID: PMC7081375.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    42. Differences Between Managed Care and Fee-for-Service Medicaid in the Use of Generics for High-Rebate Drugs: The Cases of Insulin Glargine and Glatiramer. J Manag Care Spec Pharm. 2020 Feb; 26(2):154-159. Hernandez I, Gellad WF. PMID: 32011961; PMCID: PMC7026907.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    43. Impact of community pharmacist-led interventions in chronic disease management on clinical, utilization, and economic outcomes: An umbrella review. Res Social Adm Pharm. 2020 09; 16(9):1155-1165. Newman TV, San-Juan-Rodriguez A, Parekh N, Swart ECS, Klein-Fedyshin M, Shrank WH, Hernandez I. PMID: 31959565.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    44. Impact of Healthcare Delivery System Type on Clinical, Utilization, and Cost Outcomes of Patient-Centered Medical Homes: a Systematic Review. J Gen Intern Med. 2020 04; 35(4):1276-1284. Veet CA, Radomski TR, D'Avella C, Hernandez I, Wessel C, Swart ECS, Shrank WH, Parekh N. PMID: 31907790; PMCID: PMC7174518.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    45. Risk Factors for Cardiovascular Events in Patients on Antidementia Medications. Am J Alzheimers Dis Other Demen. 2020 Jan-Dec; 35:1533317520922380. He M, Stevenson JM, Zhang Y, Hernandez I. PMID: 32383387; PMCID: PMC7315406.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    46. Impact of direct-to-consumer drug advertising during the Super Bowl on drug utilization. Res Social Adm Pharm. 2020 08; 16(8):1136-1139. Gray MP, San-Juan-Rodriguez A, Chen N, Good CB, Hernandez I. PMID: 31864886; PMCID: PMC6939613.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    47. Trends in List Prices, Net Prices, and Discounts for Originator Biologics Facing Biosimilar Competition. JAMA Netw Open. 2019 12 02; 2(12):e1917379. San-Juan-Rodriguez A, Gellad WF, Good CB, Hernandez I. PMID: 31834391; PMCID: PMC6938676.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    48. Trends in Prices, Market Share, and Spending on Self-administered Disease-Modifying Therapies for Multiple Sclerosis in Medicare Part D. JAMA Neurol. 2019 Nov 01; 76(11):1386-1390. San-Juan-Rodriguez A, Good CB, Heyman RA, Parekh N, Shrank WH, Hernandez I. PMID: 31449293; PMCID: PMC6714023.
      View in: PubMed   Mentions: 12     Fields:    
    49. Varenicline and Nicotine Replacement Use Associated With US Food and Drug Administration Drug Safety Communications. JAMA Netw Open. 2019 09 04; 2(9):e1910626. Desai RJ, Good MM, San-Juan-Rodriguez A, Henriksen A, Cunningham F, Hernandez I, Good CB. PMID: 31483473; PMCID: PMC6754175.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    50. Optimizing the Role of Community Pharmacists in Managing the Health of Populations: Barriers, Facilitators, and Policy Recommendations. J Manag Care Spec Pharm. 2019 09; 25(9):995-1000. Newman TV, Hernandez I, Keyser D, San-Juan-Rodriguez A, Swart ECS, Shrank WH, Parekh N. PMID: 31456493.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    51. Savings from the EpiPen Authorized Generic: a Retrospective Analysis of Medicaid Data. J Gen Intern Med. 2019 09; 34(9):1682-1684. Hernandez I, Shrank WH, Good CB, Gellad WF. PMID: 30945066; PMCID: PMC6712184.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    52. Impact of Star Rating Medication Adherence Measures on Adherence for Targeted and Nontargeted Medications. Value Health. 2019 11; 22(11):1266-1274. Parekh N, Munshi KD, Hernandez I, Gellad WF, Henderson R, Shrank WH. PMID: 31708063.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    53. Statins for Primary Prevention of Cardiovascular Disease. Ann Intern Med. 2019 07 02; 171(1):72. Good CB, Hernandez I, Parekh N. PMID: 31261394.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    54. Number of manufacturers and generic drug pricing from 2005 to 2017. Am J Manag Care. 2019 07; 25(7):348-352. Hernandez I, Good CB, Gellad WF, Parekh N, He M, Shrank WH. PMID: 31318508; PMCID: PMC6734551.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    55. Trajectories of Oral Anticoagulation Adherence Among Medicare Beneficiaries Newly Diagnosed With Atrial Fibrillation. J Am Heart Assoc. 2019 06 18; 8(12):e011427. Hernandez I, He M, Chen N, Brooks MM, Saba S, Gellad WF. PMID: 31189392; PMCID: PMC6645643.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    56. Assessment of Price Changes of Existing Tumor Necrosis Factor Inhibitors After the Market Entry of Competitors. JAMA Intern Med. 2019 05 01; 179(5):713-716. San-Juan-Rodriguez A, Prokopovich MV, Shrank WH, Good CB, Hernandez I. PMID: 30776053; PMCID: PMC6503568.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    57. Trends in Medicaid Prices, Market Share, and Spending on Long-Acting Insulins, 2006-2018. JAMA. 2019 04 23; 321(16):1627-1629. Hernandez I, Good CB, Shrank WH, Gellad WF. PMID: 30907933; PMCID: PMC6487544.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    58. Cardiac resynchronization therapy using pacemakers vs defibrillators in patients with nonischemic cardiomyopathy: The United States experience from 2007 to 2014. Heart Rhythm. 2019 07; 16(7):1065-1071. Saba S, McLaughlin T, He M, Althouse A, Mulukutla S, Hernandez I. PMID: 31004781.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    59. Association of Antidementia Therapies With Time to Skilled Nursing Facility Admission and Cardiovascular Events Among Elderly Adults With Alzheimer Disease. JAMA Netw Open. 2019 03 01; 2(3):e190213. San-Juan-Rodriguez A, Zhang Y, He M, Hernandez I. PMID: 30821828; PMCID: PMC6484658.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    60. The Contribution Of New Product Entry Versus Existing Product Inflation In The Rising Costs Of Drugs. Health Aff (Millwood). 2019 01; 38(1):76-83. Hernandez I, Good CB, Cutler DM, Gellad WF, Parekh N, Shrank WH. PMID: 30615532.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    61. Avoiding rash decisions about zoster vaccination: insights from cost-effectiveness evidence. BMC Med. 2018 12 18; 16(1):238. Good CB, Parekh N, Hernandez I. PMID: 30558674; PMCID: PMC6298010.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    62. Relationships between provider-led health plans and quality, utilization, and satisfaction. Am J Manag Care. 2018 12; 24(12):628-632. Parekh N, Hernandez I, Radomski TR, Shrank WH. PMID: 30586496.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    63. Accounting for All Costs in the Total Cost of Chimeric Antigen Receptor T-Cell Immunotherapy-Reply. JAMA Oncol. 2018 12 01; 4(12):1785-1786. Hernandez I, Prasad V, Gellad WF. PMID: 30325998.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    64. Changes in Drug Pricing After Drug Shortages in the United States. Ann Intern Med. 2019 01 01; 170(1):74-76. Hernandez I, Sampathkumar S, Good CB, Kesselheim AS, Shrank WH. PMID: 30242373.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    65. Lowering the P Value Threshold. JAMA. 2018 09 04; 320(9):935. Hernandez I, Gellad WF, Good CB. PMID: 30193271.
      View in: PubMed   Mentions: 2     Fields:    
    66. Impact of community pharmacist-provided preventive services on clinical, utilization, and economic outcomes: An umbrella review. Prev Med. 2018 10; 115:145-155. San-Juan-Rodriguez A, Newman TV, Hernandez I, Swart ECS, Klein-Fedyshin M, Shrank WH, Parekh N. PMID: 30145351.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansPHPublic Health
    67. Comparing state, regional, and local variation in concurrent opioid and benzodiazepine use. Drug Alcohol Depend. 2018 10 01; 191:141-144. Hernandez I, He M, Zhang Y. PMID: 30099175.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    68. Comparing the Cost Effectiveness of Non-vitamin K Antagonist Oral Anticoagulants with Well-Managed Warfarin for Stroke Prevention in Atrial Fibrillation Patients at High Risk of Bleeding. Am J Cardiovasc Drugs. 2018 Aug; 18(4):317-325. Hospodar AR, Smith KJ, Zhang Y, Hernandez I. PMID: 29740750.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    69. Total Costs of Chimeric Antigen Receptor T-Cell Immunotherapy. JAMA Oncol. 2018 07 01; 4(7):994-996. Hernandez I, Prasad V, Gellad WF. PMID: 29710129; PMCID: PMC6145722.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    70. Cost-effectiveness of the Adjuvanted Herpes Zoster Subunit Vaccine. JAMA Intern Med. 2018 06 01; 178(6):873. Good CB, Hernandez I. PMID: 29868745.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    71. Exposure-Response Association Between Concurrent Opioid and Benzodiazepine Use and Risk of Opioid-Related Overdose in Medicare Part D Beneficiaries. JAMA Netw Open. 2018 06 01; 1(2):e180919. Hernandez I, He M, Brooks MM, Zhang Y. PMID: 30646080; PMCID: PMC6324417.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    72. Teaching About the Health Care Industry Through Gamification. Am J Pharm Educ. 2018 May; 82(4):6422. Wolf C, Bott S, Hernandez I, Grieve L. PMID: 29867241; PMCID: PMC5972850.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    73. Effectiveness and Safety of Direct Oral Anticoagulants and Warfarin, Stratified by Stroke Risk in Patients With Atrial Fibrillation. Am J Cardiol. 2018 07 01; 122(1):69-75. Hernandez I, Zhang Y, Saba S. PMID: 29681367.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    74. A cost-minimization analysis of dalbavancin compared to conventional therapy for the outpatient treatment of acute bacterial skin and skin-structure infections. Expert Opin Pharmacother. 2018 Mar; 19(4):319-325. Turco NJ, Kane-Gill SL, Hernandez I, Oleksiuk LM, D'Amico F, Pickering AJ. PMID: 29509504.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    75. Pricing of monoclonal antibody therapies: higher if used for cancer? Am J Manag Care. 2018 02; 24(2):109-112. Hernandez I, Bott SW, Patel AS, Wolf CG, Hospodar AR, Sampathkumar S, Shrank WH. PMID: 29461857.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    76. Outcomes of Patients With Atrial Fibrillation Newly Recommended for Oral Anticoagulation Under the 2014 American Heart Association/American College of Cardiology/Heart Rhythm Society Guideline. J Am Heart Assoc. 2018 01 04; 7(1). Gray MP, Saba S, Zhang Y, Hernandez I. PMID: 29301756; PMCID: PMC5778974.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    77. Using predictive analytics and big data to optimize pharmaceutical outcomes. Am J Health Syst Pharm. 2017 Sep 15; 74(18):1494-1500. Hernandez I, Zhang Y. PMID: 28887351.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    78. Revisiting Outcomes-Based Pricing Propositions for the PCSK9 Inhibitor Evolocumab. JAMA Intern Med. 2017 09 01; 177(9):1388-1390. Hernandez I. PMID: 28783812; PMCID: PMC5818836.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    79. Comparison of the Effectiveness and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Newly Diagnosed Atrial Fibrillation. Am J Cardiol. 2017 Nov 15; 120(10):1813-1819. Hernandez I, Zhang Y, Saba S. PMID: 28864318.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    80. Geographic Variation in the Use of Oral Anticoagulation Therapy in Stroke Prevention in Atrial Fibrillation. Stroke. 2017 08; 48(8):2289-2291. Hernandez I, Saba S, Zhang Y. PMID: 28655815.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    81. Pharmaceutical Use and Spending Trend in Medicare Beneficiaries With Dementia, From 2006 to 2012. Gerontol Geriatr Med. 2017 Jan-Dec; 3:2333721417704946. Hernandez I, Zhang Y. PMID: 28474001; PMCID: PMC5407657.
      View in: PubMed   Mentions: 2  
    82. Comparing Adoption of Breakthrough and "Me-too" Drugs among Medicare Beneficiaries: A Case Study of Dipeptidyl Peptidase-4 Inhibitors. J Pharm Innov. 2017 Jun; 12(2):105-109. Hernandez I, Zhang Y. PMID: 28966696; PMCID: PMC5614454.
      View in: PubMed   Mentions: 1  
    83. Comparing the Approval and Coverage Decisions of New Oncology Drugs in the United States and Other Selected Countries. J Manag Care Spec Pharm. 2017 02; 23(2):247-254. Zhang Y, Hueser HC, Hernandez I. PMID: 28125371.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    84. Comparing Stroke and Bleeding with Rivaroxaban and Dabigatran in Atrial Fibrillation: Analysis of the US Medicare Part D Data. Am J Cardiovasc Drugs. 2017 Feb; 17(1):37-47. Hernandez I, Zhang Y. PMID: 27637493; PMCID: PMC6572759.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    85. Anticoagulation Use and Clinical Outcomes After Major Bleeding on Dabigatran or Warfarin in Atrial Fibrillation. Stroke. 2017 01; 48(1):159-166. Hernandez I, Zhang Y, Brooks MM, Chin PK, Saba S. PMID: 27909200; PMCID: PMC5183492.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    86. Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation at high risk of bleeding and normal kidney function. Thromb Res. 2017 Feb; 150:123-130. Hernandez I, Smith KJ, Zhang Y. PMID: 27771008.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    87. Evaluating the Initiation of Novel Oral Anticoagulants in Medicare Beneficiaries. J Manag Care Spec Pharm. 2016 Mar; 22(3):281-92. Baik SH, Hernandez I, Zhang Y. PMID: 27003558; PMCID: PMC5051348.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    88. Time to reconsider dabigatran 110 mg in the USA. Am J Cardiovasc Drugs. 2015 Oct; 15(5):307-9. Hernandez I. PMID: 26068887.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    89. Risk of Bleeding With Dabigatran in 2010-2011 Medicare Data. JAMA Intern Med. 2015 Jul; 175(7):1245-7. Hernandez I, Zhang Y. PMID: 26146922; PMCID: PMC4495572.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    90. Comparing clinical and economic outcomes of biologic and conventional medications in postmenopausal women with osteoporosis. J Eval Clin Pract. 2015 Oct; 21(5):840-7. Hernandez I, Zhang Y. PMID: 26059485; PMCID: PMC6614859.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    91. Risk of bleeding with dabigatran in atrial fibrillation. JAMA Intern Med. 2015 Jan; 175(1):18-24. Hernandez I, Baik SH, Piñera A, Zhang Y. PMID: 25365537; PMCID: PMC6608584.
      View in: PubMed   Mentions: 94     Fields:    Translation:Humans
    Inmaculada's Networks
    Concepts (278)
    Derived automatically from this person's publications.
    _
    Co-Authors (2)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _